Your browser doesn't support javascript.
loading
A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer.
Eyre, Toby A; Collins, Graham P; Gupta, Avinash; Coupe, Nicholas; Sheikh, Semira; Whittaker, John; Wang, Lai Mun; Campo, Leticia; Soilleux, Elizabeth; Tysoe, Finn; Cousins, Richard; La Thangue, Nick; Folkes, Lisa K; Stratford, Michael R L; Kerr, David; Middleton, Mark R.
Afiliación
  • Eyre TA; Early Phase Trials Unit, Churchill Hospital, University of Oxford, Oxford, United Kingdom.
  • Collins GP; Department of Clinical Haematology, Oxford Cancer Centre, Churchill Hospital, Oxford, United Kingdom.
  • Gupta A; Department of Clinical Haematology, Oxford Cancer Centre, Churchill Hospital, Oxford, United Kingdom.
  • Coupe N; Department of Medical Oncology, Christie NHS Hospital Trust, Manchester, United Kingdom.
  • Sheikh S; Early Phase Trials Unit, Churchill Hospital, University of Oxford, Oxford, United Kingdom.
  • Whittaker J; Department of Clinical Haematology, Oxford Cancer Centre, Churchill Hospital, Oxford, United Kingdom.
  • Wang LM; Laboratory of Cancer Biology, University of Oxford, Oxford, United Kingdom.
  • Campo L; Celleron Therapeutics Ltd, Oxford, United Kingdom.
  • Soilleux E; Department of Cellular Pathology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.
  • Tysoe F; GCP Laboratory, Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Cousins R; Department of Cellular Pathology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.
  • La Thangue N; Early Phase Trials Unit, Churchill Hospital, University of Oxford, Oxford, United Kingdom.
  • Folkes LK; Early Phase Trials Unit, Churchill Hospital, University of Oxford, Oxford, United Kingdom.
  • Stratford MRL; Laboratory of Cancer Biology, University of Oxford, Oxford, United Kingdom.
  • Kerr D; Celleron Therapeutics Ltd, Oxford, United Kingdom.
  • Middleton MR; CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, Department of Oncology, University of Oxford, Oxford, United Kingdom.
Cancer ; 125(1): 99-108, 2019 01 01.
Article en En | MEDLINE | ID: mdl-30332497
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Linfoma Cutáneo de Células T / Linfoma de Células T Periférico / Inhibidores de Histona Desacetilasas Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Linfoma Cutáneo de Células T / Linfoma de Células T Periférico / Inhibidores de Histona Desacetilasas Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido